Boldenone Undecylenate is a testosterone derived anabolic androgenic steroid that is best known by the trade name Equipoise given to it by Squibb in the 1970’s. While Equipoise is officially classified as a veterinarian grade anabolic steroid, the first batches of Boldenone were introduced on the human grade pharmaceutical market by Ciba in the early 1950’s under the brand name Parenabol. Human grade Boldenone would see some success in human medicine through the 1960’s and 70’s but would ultimately be discontinued by the end of the decade. Since that time, the steroid has only been available through veterinarian medicine and underground labs with the Equipoise name dominating the market. Fort Dodge Animal Health now owns the Equipoise name.
For decades, it has been assumed that Equipoise was very similar to Deca Durabolin (Nandrolone Decanoate). This assumption was in part based on comments the late Dan Duchaine made about the steroid. However, the two compounds are not similar in any way; in fact, Duchaine would recant the statement, but the initial statement has been enough to keep the rumor alive. If Equipoise shares anything in common with another anabolic steroidal hormone, it would be testosterone, but EQ as it’s commonly known is unique in its own right. An important note regarding the differences in these two steroidal hormones; Nandrolone carries a strong progestin nature, while Boldenone carries no progestin characteristics.
The effects of Equipoise are fairly straightforward. This is a generally well-tolerated anabolic steroid that presents notable anabolic activity in most users in a clean and even fashion. Outside of performance enhancement use, Boldenone did enjoy some success as a human grade steroid for a time. The steroid had some success in treating muscle wasting diseases and osteoporosis, but would ultimately give way to other steroidal options. As a veterinarian steroid, Equipoise is well-known for its use in horses, hence the name “Equipoise” and its similarity to the word “Equestrian.” EQ is often given to horses in an effort to increase lean body weight, which is in part due to the steroid’s ability to increase appetite. An increased appetite is well noted among many performance enhancing athletes that use Equipoise, however, it doesn’t appear to affect everyone the same. Many who use the anabolic steroid report no increase in appetite, it tends to be highly individualistic, but it could be useful for those struggling to consume needed calories.
Note; dosage information is only for scientific reference purposes. SARMs Central, does not condone the human consumption or use of this substance outside of a controlled scientific environment (i.e. a lab).
Standard Equipoise doses will normally fall in the 200-400mg per week range. Most men will find 400mg to be very well-tolerated and generally the minimal amount of EQ they’ll want to use. Many will also find 600mg per week to be extremely well-tolerated with side effects being extremely easy to control. However, such doses will increase estrogenic potential. Due to the long activity of the steroid, most men could easily get by with one injection per week, but splitting the weekly dose into 2-3 smaller injections will cut down on total injection volume. Further, some have reported side effects are even easier to control with a smaller more frequent injection schedule despite an extremely long half-life.
Equipoise is a generally well-tolerated anabolic steroid for most men, and is often very well-tolerated by many women when low doses are applied. Side effects of Equipoise use are certainly possible, but most healthy adults should find this anabolic steroid very manageable.Find a distributor